GP Pharma Update For Pharmacists

GP Pharma Update is a digital, medical educational publication. We reach pharmacists directly into their inbox. Should you wish to have further details about this publication, please contact us.

CPD Questions Contact us

Delivered to your inbox

Each issue is sent directly to your registered email address.

Clinically relevant content

Topics are selected specifically for pharmacy practice and medical rep needs.

CPD accredited

Earn your CPD points per issue.

CPD accreditation per issue

GP Pharma Update is CPD accredited. Complete the questions for each issue with a score of 70% or higher to earn your CPD points. You will receive a certificate which contributes to your CPD accreditation. However, you must submit it to the S.A. Pharmacy Council to complete the accreditation process.

Getting started

How to participate

This service is free and available online to all registered readers. Follow the steps below.

1
Register to create your account before earning CPD points.
2
All registrations are vetted prior to approval.
3
Only pharmacists will be approved.
4
Read the full issue from start to finish.
5
Each issue includes a set of questions based on the content covered.
6
Submit your completed answers once all questions have been answered.
7
You will receive a certificate which contributes to your CPD accreditation.
8
Please complete your CPD accreditation via the S.A. Pharmacy Council, and they will be responsible for your score.

© GP Pharma Update 2026. All Rights Reserved. No editorial or video matter published on the GP Pharma Update website may be reproduced in any form or language without written permission from the publishers. While every effort is made to ensure accurate reproduction, the authors, publishers and their employees or agents shall not be responsible or in any way liable for any errors, omissions or inaccuracies whether arising from negligence or for any consequences arising there from. The inclusion or exclusion of any product does not mean that the publisher or the editorial board advocates or rejects its use either generally or in any particular field or fields..